immunoSCAPE has the technology to deeply profile multifaceted T cell responses during pathogen infection that may be important for defining both the correlates of protective immunity, and to also identify potentially protective epitopes for incorporation into rationally-designed vaccines.

Today’s webinar will focus on the use of high-dimensional mass cytometry and a combinatorial peptide-HLA tetramer strategy to generate key insights into infectious disease & COVID-19 immune responses.